Long-Awaited CLIA Draft Guidance Offers Some Leeway For Study Design
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA draft offers flexibility for manufacturers to select comparative methods for clinical studies designed to show that tests are accurate. The Clinical Laboratory Improvement Advisory Committee meets Sept. 7-8 in Atlanta.